Overview

Impact Of Montelukast On Allergic Rhinitis And Its Inflammatory Makers

Status:
Not yet recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
To examine the efficacy of Montelukast as an adjunct to INCS in patients with allergic rhinitis.
Phase:
Early Phase 1
Details
Lead Sponsor:
Assiut University
Treatments:
Fluticasone
Montelukast
Xhance